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Abstract
OBJECTIVE: To explore the nature of "Yin internal
heat caused by Yin-deficiency," in terms of the theo-
ry of Traditional Chinese Medicine, by studying en-
ergy metabolism in rats with Yin-deficiency-heat
syndrome and analyzing the gene expression pro-
file of their livers.
METHODS: A Yin-deficiency-heat syndrome model
was induced in rats using three Chinese medicinal
herbs. Glycogen and triglycerides in blood plasma,
and the enzyme activity of ATP in livers were mea-
sured colorimetrically. Triiodothyronine (T3), thyrox-
ine (T4), and thyroid stimulating hormone levels in
blood plasma were also measured with enzyme
linked immunosorbent assay. The gene expression
profile of livers was detected with gene chip analy-
sis. Differentially expressed genes were screened
out and classified according to Gene Ontology. The
accuracy of results were examined with reverse
transcription-polymerase chain reaction.
RESULTS: Compared with the control group, body
weight (P<0.05) and hepatic glycogen (P<0.05)
were significantly lower in the Yin-deficiency-heat
syndrome group. Moreover, toe temperature (P<
0.01) and triglyceride (P<0.05), Na +-K +-ATPase (P<
0.01), Mg2 +-ATPase (P<0.01), T3 (P<0.05), and T4 (P<
0.01) levels were significantly higher. There were 99
differentially expressed genes in livers from the
Yin-deficiency-heat syndrome group. Genes were
mainly related to sterol synthesis (Pc=0.0392), de-
fense response (Pc=0.0448), and sterol metabolism
(Pc=0.0533).
CONCLUSION: Abnormal expression genes in rats
with Yin-deficiency-heat syndrome prompted the
synthesis and metabolism of cholesterol, increased
energy consumption, and reduced defense re-
sponse. This gene expression might be the molecu-
lar mechanism underlying "internal heat caused by
Yin-deficiency" in the rats with Yin-deficiency-heat
syndrome.
© 2013 JTCM. All rights reserved.
Key Words: Yin deficiency; Deficiency heat; Oligonu-
cleotide array sequence analysis
INTRODUCTION
Heat and deficiency syndromes are common in Tradi-
tional Chinese Medicine (TCM) practice. Yin-deficien-
cy-heat syndrome belongs both to heat and deficiency
syndromes. In TCM theory, "physical life is the bal-
ance of Yin and Yang."1 If Yin is deficient and cannot
counterbalance Yang, it will lead to an excess of Yang,
and vice versa. Therefore, the excessive consumption of
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Yin will lead to the pathological condition "Yin defi-
ciency and Yang hyperactivity" or "internal heat due to
Yin deficiency."
Research on Yin-deficiency-heat syndrome reported
that energy metabolism increased in rats with Yin-defi-
ciency-heat syndrome. The rats' production capacity
and energy dissipation increased as well.2 Another
study also reveled that cellular immunity decreased in
patients with Yin-deficiency-heat syndrome.3 It was al-
so reported that an increase in Tumor Necrosis Fac-
tor-α (TNF-α), Interleukin-1β (IL-1β), and Interleu-
kin-6 (IL-6) levels was associated with vexing heat in
the chest, palms, and soles of patients with Yin-defi-
ciency heat syndrome.4 The nature of Yin-deficien-
cy-heat syndrome is related to the disturbance of the
cytokine network induced by the increase of Interleu-
kin-1(IL-1) and Tumor Necrosis Factor (TNF).5 In this
study, a systematic pharmacological experiment was ap-
plied and gene chip technology was used to explore the
nature of internal heat induced by Yin deficiency.
METHODS
Experimental animals
Twenty SPF Wistar rats, half male and half female,
weighing (200±20) g, were purchased from the experi-
mental animal center of Shandong Lukang Pharmaceu-
tical Co. Ltd. (Jining, China). The animal certification
number was SCXK (Lu)20080002.
Herbs and reagents
Fuzi (Radix Aconiti Lateralis Preparata) was harvested
in Jangyou, Sichuan province; Rougui (Cortex Cinna-
momi Cassiae) in Dayao, Guangxi province; and Ganji-
ang (Rhizoma Zingiberis) in Qianwei, Sichuan prov-
ince. Plants were identified by an expert of Chinese ma-
teria medica. ATPase assay (Lot No. 20090821) and
glycogen kits (Lot No. 20100610) were provided by
Nanjing Jiancheng Bioengineering Institute (Nanjing,
China). Triglyceride test was obtained from North of
Clinical Reagent Co, Ltd. Hong Thai (Beijing, China).
One Touch Ultra blood glucose test strips (Lot No.
2897340) were obtained from Johnson and Johnson
Co, Ltd. (New Brunswick, NJ, USA). Rat triiodothyro-
nine (T3), thyroxine (T4), and thyroid stimulating hor-
mone (TSH) enzyme linked immunosorbent assay
(ELISA) kits were purchased from Alpha Diagnostic In-
tl., Inc. (San Antonio, Tx, USA). Rat Ref-12 v1 Expres-
sion BeadChip (Bar Code 4562019003) was provided
by Illumina Co, Ltd. (Santiago, CA, USA).
Procedure and data collection
Animals were randomly divided into a control group
(n=10) and a model group (n=10). The decoction was
prepared with Fuzi (Radix Aconiti Lateralis Preparata),
Rougui (Cortex Cinnamomi Cassiae), and Ganjiang
(Rhizoma Zingiberis) in the ratio 1∶1∶1. The decoction
was intragastrically administered to the treatment
group at 32 g/kg－1·day－1 for 14 days. The rectal tem-
perature and toe temperature were measured on the
day before the experiment, and the 7th and 14th days
after the model establishment.
After the treatment course was finished, the animals
fasted for 8 h. Then, blood samples were taken from
the abdominal aorta. Hepatic glycogen and plasma tri-
glycerides were examined with a chemical colorimetric
method. The levels of Triiodothyronine (T3), thyroxine
(T4), and thyroid stimulating hormone (TSH) in
blood plasma were measured with enzyme-linked im-
muno sorbent assay (ELISA). The activities of Na+-K+-,
Mg2 +-, Ca2 +-, and Ca2 +-Mg2 +-ATPases were examined
colorimetrically.
After sacrifice, the rats' livers were harvested at 4℃ and
frozen in liquid nitrogen. The whole genome expres-
sion of livers was examined with a gene chip. The total
RNA in hepatic tissue was extracted with unizol. The
amount and quality of RNA was verified with a Gene-
Quant Pro and 1% agarose gel electrophoresis. RNA
amplification was carried out according to the Illumi-
na® TotalPrep RNA amplification kit.
(a) The first strand complementary Deoxyribonucleic
acid (cDNA) was synthesized with the T7 Oligo (dT)
by reverse transcription; (b) The second strand cDNA
was synthesized by converting the single-stranded cD-
NA into a double-stranded DNA (dsDNA) template
for transcription; (c) cDNA was purified by removing
RNA, primers, enzymes, and salts; (d) complementary
Ribonucleic Acid (cRNA)was transcribed and synthe-
sized in vitro; (e) cRNA was purified and ready for use
with Illumina's array kit by removing unincorporated
Nucleoside triphosphates (NTPs), salts, and enzymes.
The probes were labeled with Cy3-labeled 2'-Deoxyuri-
dine 5'- Triphosphate (Cy3-dUTP). After hybridizing,
washing, and staining, the chip was scanned by an Illu-
mina 500 system Beadstation scanner and the acquired
image was analyzed using Illumina BeadStudio soft-
ware (Illumina,Inc., San Diego, CA, USA).
RT1-Ba, Ephx2, and Fos were used as target genes and
Actb was used as a housekeeping gene, which was ran-
domly selected for Real-Time Quantitative polymerase
chain reaction (RTQ-PCR) to verify the gene chip.
RTQ-PCR was performed using an ABI 7900 re-
al-time PCR system. The primer 5.0 software (Premier
Biosoft International, CA, USA) was used to design
the primer sequences. The primer sequences were syn-
thesized by Shanghai Biostar Genechip, Inc., China.
The primer sequences of RT1-Ba were: forward prim-
er, 5'-GGCACCATCTTCATCATTCAA-3'; reverse
primer, 5'-AGAGCCACGCACCTTCTTT-3'. The
primer sequences of Ephx2 were: forward primer,
5'-CAAGTGGCTGAAGACTGAAATCC -3'; reverse
primer, 5'-AGAACGATGCTGCTGGCTGT-3'. The
primer sequences of Fos were: forward primer,
5'-GAGCCGGTCAAGAACATTAGC-3'; reverse
primer, 5'-AAGGAACCAGACAGGTCCACAT-3'.
The relative quantitative 2-ΔΔCt method was used to ana-
lyze the results. The experiment was repeated 3 times.
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Data analysis
Data were analyzed with SPSS 13.0 (SPSS Inc. Chica-
go, IL, USA) and one-way ANOVA. P <0.05 were con-
sidered significant. Cubic Spline was used for the nor-
malization of data. DiffScore >+20 (up-regulation) or
DiffScore <− 20 (down-regulation) were the selection
criteria for differentially expressed genes according to
their functions. The differentially expressed genes were
analyzed by Gene Ontology (GO) with Agilent Gene-
spring GX 11 software (Agilent Technologies Co. Ltd.,
Parrot, CA, USA). P values <0.1 were considered signif-
icant in detecting gene function.
RESULTS
Comparison of body weight, rectal temperature, and
toe temperature
Before experiment there were no significant differences
between the two groups in body weight, rectal tempera-
ture, or toe temperature. There was a significant reduc-
tion in body weight of the model group on the 7th day
after treatment (P=0.00) and the 14th day after model
establishment (P=0.03). A significantly lower toe tem-
perature was observed in the model group on the 7th
day (P=0.00) and 14th day (P=0.005) compared with
the control group. There was also a significant decrease
in toe temperature on the 14th day (P=0.007) com-
pared with the day before the experiment in the model
group. The difference between the two groups in rectal
temperature was insignificant (Figure 1-3).
Comparison of blood sugar, hepatic glycogen and
triglyceride in blood plasma
There was significantly lower hepatic glycogen (P=
0.033), significantly higher plasma triglycerides (P=
0.048), and no significant difference in blood glucose
between the model and control groups, respectively
(Table 1).
Comparison of the activities of Na+-K+-, Mg2+-, Ca2+-,
and Ca2+-Mg2+-ATPases
As shown in Figure 4, there was a significantly higher
Na+-K+-ATPase (P=0.007) and Mg2+-ATPase (P=0.006)
activity in the model group compared with the control
group. There were no differences in Ca2 +-ATPase or
Ca2+-Mg2+-ATPase activities between the two groups.
Comparison of the content of T3, T4, and TSH in
blood
There was significantly higher level of T3 (P=0.028)
and T4 (P=0.00) in the model group compared with
the control group (Figures 5). The content of TSH in
blood of the model group is 0.87 ng/mL, in blood of
the control group is 1.36 ng/mL. No significant differ-
Before experiment 7 d 14 d
Bo
dy
we
igh
t(g
)
Model group Control group
400
300
200
100
0
Figure 1 Changes in body weight of Yin-deficiency-heat syn-
drome model group
aP<0.01, compared with the control group; bP<0.05, com-
pared with the control group.
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Figure 4 Changes in ATPase activity of Yin-deficiency-heat
syndromemodel group
A: Na +-K +-ATPase; B: Mg2 +-ATPase; C: Ca2 +-ATPase; D:
Ca2+-Mg2+-ATPase. aP<0.01, compared with the control group.
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Figure 3 Changes in toe temperature of Yin-deficiency-heat
syndromemodel group
aP<0.01, compared with the control group.
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Figure 2 Changes in rectal temperature of Yin-deficien-
cy-heat syndromemodel group
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ence was found in TSH levels between the two groups.
Comparison of the gene expression profile of liver
The total RNA ratio was OD260/OD280 >1.8 in each
group, and the total RNA had no degradation, as
found with 1% agarose gels electrophoresis. Chip scan-
ning figure of the model group and the control group
shown in Figure 7. Compared with the control group,
there were 99 strips of differentially expressed genes in
the model group. Within the 99 genes, there were 60
up-regulated genes and 39 down-regulated genes. Us-
ing Agilent Genespring GX 11 analysis software (Agi-
lent Technologies, Santa Clara, CA, USA), the func-
tion of each differentially expressed gene was analyzed.
Gene Ontology classification was used to analyze gene
function. 55 genes were annotated. The software found
that three biological processes were the significant gene
functions. These processes included sterol biosynthetic
process (P=0.0392), defense response (P=0.0448), and
sterol metabolic process (P=0.0533). Differentially ex-
pressed genes associated with the above-mentioned
functions are in Table 2.
Results of RT-PCR
The 2-ΔΔCt values of RT1-Ba, Ephx2, and Fos were
0.398 997, 4.904 289, and 0.397 581, respectively.
The values, being consistent with the study of gene
chip, indicated the reliability of the results.
DISCUSSION
Since the 1980s, Liang et al 6 have studied cold and
heat syndromes in Beijing Medical University. They no-
ticed that patients with heat syndrome can transform
into deficiency-induced cold syndrome if medication
with cold-properties are overdosed. Moreover, patients
with deficiency-induced cold syndrome could develop
into Yin-deficiency-heat syndrome if medication with
warm-properties are overdosed. Moreover, medication
with cold-properties might induce Yin-deficiency-heat
syndrome or cold syndrome. Therefore, Liang et al 7,8
began to produce animal models with cold or heat syn-
dromes by giving mice large doses of medication with
cold-properties or heat-properties. According to TCM
theory, medication with cold-properties can weaken
Yang, and Yang-deficiency can lead to cold syndrome.
Medication with warm-properties is likely to damage
Yin, which may generate "endogenous pathogenic
fire". Chen et al 9,10 thought that Liang's animal models
could be generally accepted. However, the models
could not reach the standard of deficiency-induced
cold syndrome if the medication dose was not high
enough or treatment course was not long enough. In
this experiment, we tried to improve the model by in-
creasing the doses of medication to much larger than
Liang's. A few deaths occurred after the rats took the
decoction for 2 weeks and mortality increased as time
elapsed. This suggested that the proper time for creat-
ing a model was 14 days.
In this study, we found that there was a significantly
lower body weight and glycogen level, and significantly
higher toe temperature, triglyceride level, Na+-K+- and
Mg2+-ATPase activity, and T3 and T4 levels in the model
group compared with the control group. This showed
that energy metabolism in rats with Yin-deficien-
cy-heat syndrome was enhanced, reflecting the state of
heat syndrome.
Through analysis of the gene expression profile of the
livers, 99 strips of differentially expressed genes be-
tween the model and control groups were mainly relat-
ed to the function of sterol synthesis and metabolism,
and the defense response.
Cholesterol synthesis and metabolism in
Yin-deficiency-heat syndrome rats were up-regulated
Scd1 coding Stearoyl-Coenzyme A desaturase 1
(SCD1) is a rate-limiting enzyme converting saturated
fatty acids (SFA) to monounsaturated fatty acids (MU-
FA). SCD1 plays an important role in the regulation of
fatty acid metabolism and energy balance.11 Abcg5 cod-
ing ATP-binding cassette, sub-family G, member 5
(ABCG5) involves reverse transportation of cholesterol
and plays an important role in the decrease of cholester-
ol absorption in intestine, the increase of steroid excre-
tion in liver, the control of steroid level in plasma and
the maintenance of steroid balance in body.12 Acat2
coding acyl coenzyme A: cholesterol acetyltransferase
(ACAT2) is mainly in the liver cells and the epithelial
Figure 5 Changes in T3, T4 in bood of Yin-deficiency-heat
syndromemodel group
TSH: thyroid stimulating hormone. T3: Triiodothyronine, T4:
thyroxine. aP<0.01, compared with the control group; bP<
0.05, compared with the control group.
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Figure 7 Chip scanning figure of the two groups
A: model group; B: control group.
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cells of intestinal villi. It can catalyze long chain fatty
acids and cholesterol into cholesterol esters. It also
plays an important role in the absorption, transport
and storage of cholesterol.13 Sqle coding squalene epoxi-
dase can catalyze squalene into squalene epoxide,
which can turn into lanosterol and create cholesterol.
It is a rate-limiting enzyme in cholesterol biosynthesis.
Sc4mol coding sterol-C4-methyl oxidase-like protein
also takes part in the metabolism of fatty acid and bio-
synthesis of cholesterol. Ephx2 coding soluble epoxide
hydrolase (sEH) mainly takes part in the metabolism
of endogenous fatty acid epoxides. The up-regulation
of Ephx2 could promote the metabolism of endoge-
nous fatty acid epoxides.14
Table 2 Expression profile of genes in the model group
GenBank accession
Genes about sterol biosynthetic and metabolic
NM_001013098
NM_022936
NM_139192
NM_053754
NM_001006995
NM_080886
NM_017136
NM_001013071
NM_017268
Genes about defense response
NM_001025004
NM_058208
NM_001009488
NM_139089
NM_021835
NM_017019
NM_053299
NM_001033691
NM_053960
NM_145672
NM_001008847
NM_020096
NM_198741
NM_013069
NM_022197
NM_001008884
NM_022266
NM_031512
NM_001008831
Symbol
Dhrs7
Ephx2
Scd1
Abcg5
Acat2
Sc4mol
Sqle
Tm7sf2
Hmgcs1
Vsig4
Socs2
Ly49s6
Cxcl10
Jun
Il1a
Ubd
Irf7
Ccr5
Cxcl9
RT1-Da
Ifit1
Hla-dma
Cd74
Fos
RT1-Db1
Ctgf
Il1b
RT1-Ba
Definition
Dehydrogenase/reductase member 7
Epoxide hydrolase 2, cytoplasmic
Stearoyl-Coenzyme A desaturase 1
ATP-binding cassette, sub-family G , member 5
Acetyl-Coenzyme A acetyltransferase 2
Sterol-C4-methyl oxidase-like
Squalene epoxidase
Transmembrane 7 superfamily member 2
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
V-set and immunoglobulin domain containing 4
Suppressor of cytokine signaling 2
Ly49 stimulatory receptor 6
Chemokine ligand 10
Jun oncogene
Interleukin 1 alpha
Ubiquitin D
Interferon regulatory factor 7
Chemokine receptor 5
Chemokine ligand 9
RT1 class II, locus Da
Interferon-induced protein with tetratricopeptide repeats 1
Major histocompatibility complex, class II, DM alpha
CD74b antigen
FBJ murine osteosarcoma viral oncogene homolog
RT1 class II, locus Db1
Connective tissue growth factor
Interleukin 1 beta
RT1 class II, locus Ba
DiffScorea
59.221 53
53.771 42
46.195 18
39.978 34
31.828 24
25.870 08
20.964 66
20.677 04
20.113 82
103.7418
48.831 77
-20.262 38
-21.118 95
-21.2906
-21.820 93
-22.649 04
-25.081 14
-26.135 97
-28.059 72
-28.756 39
-32.924 63
-36.130 64
-38.560 15
-45.638 87
-46.481 01
-54.139 23
-67.188 53
Notes: acompared with the control group; bCluster of Differentiation 74.
Group
Model group
Control group
Blood sugar (mg/dL)
70.9±5.6
74.0±6.1
Plasma triglyceride (mg/g)
26.4±5.5a
21.1±4.2
Glycogen (mg/g)
4.0±1.2a
5.3±0.9
Table 1 Changes in energy metabolism of Yin-deficiency-heat syndromemodel group
Note: aP<0.05, compared with the control group.
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Changes in gene expression related to defense
response in rats with Yin-deficiency-heat syndrome
Vsig4 coding V-set and Ig domain-containing 4
(VSIG4) is the costimulator of the B7 clan, which
plays an important role in the activation and survival
of T cells. It is the only costimulator which shows spe-
cific expression on the macrophage surface;15,16 Ccr5
coding CC-chemokine receptor 5 (CCR5) is the specif-
ic receptor of chemokine ligand 3 (CCL3) and chemo-
kine ligand 5 (CCL5). CCR5 is mainly expressed in
mononuclear cells, T cells, and other white blood cells.
It is thought to be the surface marker of the activation
of Thl cells.17 Cxcl10 codes CXC-Chemokine Ligand
10 (CXCL10). After CXCL10 is combined with
CXC-chemokine receptor 3 (CXCR3), the CXCR3
positive cells can activate and migrate to inflammatory
lesions. CXCL9 codes CXC-Chemokine Ligand 9 (CX-
CL9). CXCL9 has a chemotactic effect on activating T
lymphocytes and monocytes. CXCL9 plays an impor-
tant role in a variety of autoimmune diseases, inflam-
matory diseases, and cancer;18 Il1α codes interleukin
1α and Il1β codes interleukin 1β. IL-1 is a key cyto-
kine in the initiation of the inflammatory response.
IL-1 affects a variety of immune cells and plays an im-
portant role in the elimination of foreign microorgan-
isms, inhibition of tumor cell growth, and mainte-
nance of internal environment in balance.19 Irf7
codes interferon regulatory factor 7 (IRF7). IRF is a
multifunctional transcription factor which can regu-
late the gene expression of interferon. IRF7 is the
main regulatory factor which can induce the expres-
sion of interferon.20
Overall, energy metabolism in rats with Yin-deficien-
cy-heat syndrome was enhanced. This reflected, in
terms of TCM theory, the pathogenesis of hyperactivi-
ty of Yang and endogenous heat. The molecular mecha-
nism might be that cholesterol synthesis and metabo-
lism genes were up-regulated. Meanwhile, the genes
down-regulating the defense response may be related to
the "depletion of vital essence resulting in deficiency
syndrome" and "internal heat induced by Yin-deficien-
cy." Therefore, Yin-deficiency-heat syndrome can be ex-
plained as abnormal gene expression related to sterol
synthesis, sterol metabolism and defense response.
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